| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/24/2006 | CN1256967C Health-preserving liver-protecting drug and method for making same |
| 05/24/2006 | CN1256963C Antifatigue medicine and its preparation method |
| 05/24/2006 | CN1256953C Senility-delaying health caring medicine |
| 05/23/2006 | US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049319 Colon cleansing composition and method |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2428870C Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/23/2006 | CA2312729C Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/18/2006 | WO2006052889A2 Quinolinone-carboxamide compounds |
| 05/18/2006 | WO2006052640A1 5-ht4 receptor agonist compounds |
| 05/18/2006 | WO2006052013A1 Thienopyrrole compounds and utilization thereof as hcv polymerase inhibitor |
| 05/18/2006 | WO2006051937A1 Five-membered heterocyclic derivatives |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051312A1 Gastrin and cholecystokinin receptor ligands |
| 05/18/2006 | WO2006025072A3 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106111 Phenylnaphthalene compounds |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106056 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106055 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106003 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105985 Treatment of mucositis |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105948 GLP-2 derivatives |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656933A1 A medicinal composition comprising L-alanine for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis and use therof |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1558252A4 Substituted furo 2,3-b| pyridine derivatives |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/17/2006 | EP1372661B1 Glycol derivatves of xanthines for treating irritable bowel syndrome |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1274711B1 New aza-indolyl derivatives |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0938900B1 Preventives/remedies for stomatitis |
| 05/17/2006 | EP0937077B1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 05/17/2006 | CN1772902A One coding gene of rotavirus VP6 protein and its application |
| 05/17/2006 | CN1772765A Bionic affinity purifying process of interleukin I natural agonist |
| 05/17/2006 | CN1772296A New use of prophymosin-alpha |
| 05/17/2006 | CN1772292A Nutrient for preventing sudden death |
| 05/17/2006 | CN1772291A Nanometer granule prepn of bufanin albumin and its prepn process |
| 05/17/2006 | CN1772287A Application of hedgehog fungus mycelium glucoprotein in preparing medicine |
| 05/17/2006 | CN1772286A Vital energy benefiting and blood nourishing medicine composition |
| 05/17/2006 | CN1772275A Medicine for treating diseases of intestine, spleen and kidney and its making process |
| 05/17/2006 | CN1772274A Recipe of navel plaster for treating enteritis quickly |
| 05/17/2006 | CN1772272A Food antibiotic and its prepn |
| 05/17/2006 | CN1772270A Tiantan prepn for treating kidney-yang deficiency diseases and its production process |
| 05/17/2006 | CN1772269A Medicine composition for treating chronic hepatitis and its prepn |
| 05/17/2006 | CN1772267A Medicine composition for treating functional indigestion and its prepn |
| 05/17/2006 | CN1772257A Fatty liver treating notoginseng prepn and its prepn process |
| 05/17/2006 | CN1772255A Chinese medicine for treating liver cancer and carcinoma of pancreas |
| 05/17/2006 | CN1772253A Chinese medicine for treating chronic hepatitis B |
| 05/17/2006 | CN1772248A Gastric ulcer treating medicine |
| 05/17/2006 | CN1772243A Gastropathy treating medicine |
| 05/17/2006 | CN1772241A Stomachache treating Chinese medicine |
| 05/17/2006 | CN1772240A Gastropathy treating medicine |